Related Experiment Video
Updated: Mar 22, 2026
10:52
Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
Published on: March 30, 2018
11.7K
Which Patients With Mantle Cell Lymphoma Do Not Need Aggressive Therapy
1Division of Hematology and Medical Oncology, Meyer Cancer Center, Weill Cornell Medical College, 1305 York Avenue, New York, NY, 10065, USA. jruan@med.cornell.edu.
Current Hematologic Malignancy Reports
|April 13, 2016
Summary
Mantle cell lymphoma (MCL) can present indolently in some patients. Risk-stratified approaches are crucial for tailoring treatment, optimizing survival, and improving quality of life by identifying those who benefit from watchful waiting versus immediate therapy.
Area of Science:
- Hematology
- Oncology
- Clinical Pathology
Background:
- Mantle cell lymphoma (MCL) exhibits significant heterogeneity.
- A subset of MCL patients presents with an indolent disease course.
- Current management strategies necessitate risk stratification for optimal patient outcomes.
Purpose of the Study:
- To review clinical and pathological factors associated with indolent MCL.
- To identify predictive biomarkers for disease course.
- To guide initial treatment decisions based on risk assessment.
Main Methods:
- Comprehensive literature review of indolent mantle cell lymphoma.
- Analysis of clinical presentation and pathological features.
- Evaluation of prognostic and predictive biomarkers.
Main Results:
- Identified key clinical and pathological entities linked to indolent MCL.
- Delineated biomarkers with predictive significance for disease progression.
- Highlighted the importance of risk assessment in treatment planning.
Conclusions:
- Risk-stratified management is essential for indolent MCL.
- Deferred therapy may be suitable for low-risk patients.
- Non-aggressive first-line regimens are indicated for higher-risk patients.
Related Concept Videos
01:22Bone Marrow Sampling and Transplants
2.3K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.3K
02:57Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
01:16Primary Lymphoid Organs
16.5K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
16.5K
02:56Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
01:15Secondary Lymphoid Organs
10.2K
Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
10.2K
01:18Lymphoid Cells and Tissues
3.7K
Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
3.7K